Krka Banned from Selling Monkasta in Poland
Novo Mesto/Warsaw, 28 January - Krka Polska has been banned from producing and selling a drug containing the active ingredient montelukast. Slovenian pharma Krka said its Polish subsidiary would challenge the temporary injunction issued by the Warsaw Business Court.
The rest of this news item is available to subscribers.
The news item consists of 639 characters (without spaces) or 124 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.